Your Search Returned 20 tagged news reports
57, Gali Weinreb When an Israeli company nears the sales stage, the debate whether it is time to hire an American CEO almost always begins. A man who knows the target market, has more experience in sales (very few Israeli managers of life sciences
Global alternative asset manager The Carlyle Group ( Nasdaq: CG ) and AlpInvest Partners today announced that they have assumed management of two funds of funds with a focus on Indiana life sciences companies: the Indiana Future Fund (IFF), a $72.
Filed Under On Oct. 31, Life Sciences organizations in Greater Cincinnati can learn how to take their workforces to the next level at the sixth annual Blue Ash Life Sciences Collaborative. The theme of the event, which will be from 8:30 a.m. to 11 a.
40, Gali Weinreb In early 2013, the idea that, within a few months, a discussion on IPO trends by Israeli life sciences companies on Wall Street would be held would have seemed ridiculous. But even then, it was known that the life sciences were hot
A massive research and design, and manufacturing facility proposed for a vacant parcel on the South Boston waterfront could fill a growing need for space for life sciences companies, according to an industry watcher. Kavanagh Advisory group has filed
Dan Cahill , 1-917-617-0106, email@example.com More by this
Bridge Medical is developing a communications platform to enable information sharing between implanted devices and physicians, patients, hospitals and implant manufacturers, resulting in improved patient care. For example, iBridge's technology
Alcobra files for Nasdaq IPO The life sciences company reportedly plans to raise $15-20 million at a company value of $100 million. US Securities and Exchange Commission (SEC) to hold an IPO on Nasdaq. The company reportedly plans to raise $15-20
QA staff by life sciences cos Jobinfo attributes the growth to the growing number of companies undergoing clinical trials, or which have begun production. July 12 13:18, Gali Weinreb Online job placements site Jobinfo reports a 22% increase in
Bioassociate Biotech Business Consulting Ltd. founder and managing partner Dr. Ofir Levi and Tiran Rothman. They add that this fact is indicative of an inefficient market. The report's logic is that investors apparently do not understand the